WAYNE, Pa., Feb. 8, 2016 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing ...
In light of the recent nationwide shortage of Ketorolac Tromethamine Injection, Regency Therapeutics, a division of Luitpold Pharmaceuticals, is alerting surgery centers, hospitals and health systems ...
WAYNE, Pa., March 25, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing ...
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on discovering, developing, and commercializing innovative pain treatments, today announced ...
SPRIX (ketorolac tromethamine) 15.75mg/100µL nasal spray by Regency Therapeutics & Daiichi Sankyo The FDA has approved Sprix (ketorolac tromethamine nasal spray, from Roxro Pharma) for the short-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback